ARG42454

anti-uPAR antibody [VIM5] (PE)

anti-uPAR antibody [VIM5] (PE) for Flow cytometry and Human

Overview

Product Description PE-conjugated Mouse Monoclonal antibody [VIM5] recognizes uPAR
Tested Reactivity Hu
Tested Application FACS
Specificity The mouse monoclonal antibody VIM5 recognizes CD87 (urokinase plasminogen activator receptor), a 36-68 kDa single-chain GPI-anchored extracellular glycoprotein expressed on granulocytes, monocytes/macrophages, dendritic cells, endothelial cells, fibroblasts and keratinocytes.
Host Mouse
Clonality Monoclonal
Clone VIM5
Isotype IgG1
Target Name uPAR
Antigen Species Human
Immunogen Human myeloid cell line THP-1.
Conjugation PE
Alternate Names Monocyte activation antigen Mo3; CD antigen CD87; uPAR; U-PAR; URKR; Urokinase plasminogen activator surface receptor; UPAR; CD87

Application Instructions

Application Suggestion
Tested Application Dilution
FACS10 µl / 100 µl of whole blood or 10^6 cells
Application Note * The dilutions indicate recommended starting dilutions and the optimal dilutions or concentrations should be determined by the scientist.

Properties

Form Liquid
Purification Purified
Buffer PBS and 15 mM Sodium azide.
Preservative 15 mM Sodium azide
Storage Instruction Aliquot and store in the dark at 2-8°C. Keep protected from prolonged exposure to light. Avoid repeated freeze/thaw cycles. Suggest spin the vial prior to opening. The antibody solution should be gently mixed before use.
Note For laboratory research only, not for drug, diagnostic or other use.

Bioinformation

Database Links

GeneID: 5329 Human PLAUR

Swiss-port # Q03405 Human Urokinase plasminogen activator surface receptor

Gene Symbol PLAUR
Gene Full Name plasminogen activator, urokinase receptor
Background This gene encodes the receptor for urokinase plasminogen activator and, given its role in localizing and promoting plasmin formation, likely influences many normal and pathological processes related to cell-surface plasminogen activation and localized degradation of the extracellular matrix. It binds both the proprotein and mature forms of urokinase plasminogen activator and permits the activation of the receptor-bound pro-enzyme by plasmin. The protein lacks transmembrane or cytoplasmic domains and may be anchored to the plasma membrane by a glycosyl-phosphatidylinositol (GPI) moiety following cleavage of the nascent polypeptide near its carboxy-terminus. However, a soluble protein is also produced in some cell types. Alternative splicing results in multiple transcript variants encoding different isoforms. The proprotein experiences several post-translational cleavage reactions that have not yet been fully defined. [provided by RefSeq, Jul 2008]
Function Acts as a receptor for urokinase plasminogen activator. Plays a role in localizing and promoting plasmin formation. Mediates the proteolysis-independent signal transduction activation effects of U-PA. It is subject to negative-feedback regulation by U-PA which cleaves it into an inactive form. [UniProt]
Cellular Localization Cell membrane. Cell projection, invadopodium membrane. Note=Colocalized with FAP (seprase) preferentially at the cell surface of invadopodia membrane in a cytoskeleton-, integrin- and vitronectin-dependent manner. Isoform 1: Cell membrane; Lipid-anchor, GPI-anchor. Isoform 2: Secreted. [UniProt]
Calculated MW 37 kDa

Images (2) Click the Picture to Zoom In

  • ARG42454 anti-uPAR antibody [VIM5] (PE) FACS image

    Flow Cytometry: Human peripheral whole blood stained with ARG42454 anti-uPAR antibody [VIM5] (PE) at 10 µl / 100 µl of peripheral whole blood.

  • ARG42454 anti-uPAR antibody [VIM5] (PE) FACS image

    Flow Cytometry: Separation of Human monocytes (red-filled) from lymphocytes (black-dashed). Human peripheral whole blood stained with ARG42454 anti-uPAR antibody [VIM5] (PE) at 10 µl / 100 µl of peripheral whole blood.